Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

235 Preclinical evaluation and clinical scale-up of virus-free CRISPR GD2 CAR T cells

8 more authors
9 affiliations
  1. 1Senior Department of Infectious Diseases, Chinese PLA General Hospital, Beijing, China
  2. 2University of Wisconsin-Madison, Madison, WI, USA
  3. 3Aff1 0000 0001 2284 9329grid.410427.4Department of MedicineAugusta University 1120 15th St 30912 Augusta GA USA
  4. 41Trophoblastic Disease Unit, Charing Cross Hospital, Imperial College, London, UK
  5. 51 Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland
  6. 6Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA
  7. 71University of Wisconsin-Madison, Madison, WI, USA
  8. 81Lyell Immunopharma, South San Francisco, CA, USA
  9. 9Cellares, South San Francisco, CA, USA

Related

  1. Discovery and preclinical evaluation of ZLC853 as a potential clinical candidate covalently targeting CDK12/13 kinases
    Kaijie Zhou, Licheng Zhou, Jean C. Tien +23
    Acta pharmaceutica Sinica. BPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Clinical Evaluation of the PANDAA Lassa Virus RT-PCR Assay in Sierra Leone
    D. S. Grant, C. R. Thompson, J. Sandi +7
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  3. Advances in CRISPR‐based detection technologies for severe fever with thrombocytopenia syndrome virus (Dabiebanda virus): A mini review
    Junhu Wang, Changqiang Zhu, Jinzhao Chu +6
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textInfectious diseaseDOAJ
  4. The effect of preoperative hospital anxiety and depression scale evaluation on the clinical outcomes following posterior lumbar interbody fusion
    Luc W.F. van Haaster, Joep Kitzen, Gijsbert M. Overdevest +3
    Brain & SpinePeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. 321 Genome-scale CRISPR KO screen identifies PCBP2 as a tumor-intrinsic regulator of cancer cell sensitivity to human CD4+ T cell killing
    Paul Chapman, Iñaki Etxeberría, Benjamin Izar +19
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
BibTeX
@article{shi2026preclinical,
  title = {{235 Preclinical evaluation and clinical scale-up of virus-free CRISPR GD2 CAR T cells}},
  author = {Lei Shi and Jacques Galipeau and Quaovi Sodji and Anna Tommasi and Rohini Emani and Dan Cappabianca and Krishanu Saha and Matthew Forsberg and Jessica Fioravanti and Evan L Dray and Christian M Capitini and Portia R Smith and Dmitry Malkov and Karthik Shastry and Victor Rocha and Julie Fang and Anikait Patel and Grace Reimers and Ross O Meyers and Austin J Stuckert},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0235},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0235},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 235 Preclinical evaluation and clinical scale-up of virus-free CRISPR GD2 CAR T cells
AU  - Lei Shi
AU  - Jacques Galipeau
AU  - Quaovi Sodji
AU  - Anna Tommasi
AU  - Rohini Emani
AU  - Dan Cappabianca
AU  - Krishanu Saha
AU  - Matthew Forsberg
AU  - Jessica Fioravanti
AU  - Evan L Dray
AU  - Christian M Capitini
AU  - Portia R Smith
AU  - Dmitry Malkov
AU  - Karthik Shastry
AU  - Victor Rocha
AU  - Julie Fang
AU  - Anikait Patel
AU  - Grace Reimers
AU  - Ross O Meyers
AU  - Austin J Stuckert
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0235
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0235
SN  - 2051-1426
ER  -